Pneumococcal Infections
📧 Sign up to get email alerts when something new happens for Pneumococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001) [Phase 1]
Phase 1 safety and tolerability trial comparing V114 to Prevnar for pneumococcal infection indications has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002) [Phase 2]
Phase 2 trial assessing safety, tolerability, and immunogenicity of a single dose of V114, PNEUMOVAX 23, or PREVNAR 13 in adults 50+; result…
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. [Phase 3]
Phase 3 safety and immunogenicity results for a booster dose of GSK's 10-valent pneumococcal conjugate vaccine have been completed with resu…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005) [Phase 1, Phase 2]
Clinical trial evaluating safety, tolerability, and immunogenicity of V114 in healthy adults and infants (Phase 1/2) has completed with resu…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae [Phase 2]
Phase 2 clinical trial update evaluating the safety, tolerability, and efficacy of a prophylactic Streptococcus pneumoniae vaccine after del…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults [Phase 1]
Phase I clinical trial update on LG Life Sciences' 13-valent and 14-valent pneumococcal conjugate vaccines in adults has been completed.
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens
A completed UC Davis clinical trial evaluated whether milk components influence the immune response to pneumococcal vaccines in elderly adul…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Evaluation of Pneumococcal Vaccine Formulations in Elderly [Phase 1]
GlaxoSmithKline conducted a Phase 1 evaluation of pneumococcal vaccine formulations in elderly adults; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly [Phase 3]
A Phase 3 trial update reports on the safety and immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in healthy children, adul…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Phase 3]
A Phase 3 clinical trial evaluated safety and immunogenicity of a booster dose of pneumococcal conjugate vaccine in preterm born infants; re…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule [Phase 3]
This Phase 3 study evaluated the safety and immunogenicity of a two-dose schedule of the 10-valent pneumococcal conjugate vaccine and posted…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts [NA]
A completed clinical trial evaluating system-level strategies to improve influenza and pneumococcal vaccination rates through patient outrea…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso [Phase 4]
Phase 4 clinical trial update assessing immunogenicity and reactogenicity of PCV13 in infants and children in Burkina Faso; the study has co…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea
A post-marketing safety surveillance study evaluating the Synflorix pneumococcal vaccine in Korean infants has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection [Phase 3]
Phase 3 immunogenicity and safety study of Synflorix pneumococcal vaccine in children at increased risk of pneumococcal infection has comple…
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Pneumococcal Reference Standard [Phase 1]
Phase 1 trial of a pneumococcal reference standard has completed, according to the sponsor NIAID.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. [Phase 3]
This is a completed Phase 3 safety and immunogenicity study of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 safety and immunogenicity study evaluating a booster dose of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine; the trial s…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. [Phase 3]
This update reports the completion of a Phase 3 trial evaluating immune memory in children after primary vaccination with pneumococcal conju…
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study [Phase 3]
A Phase 3 non-inferiority study evaluated lot-to-lot consistency across three lots of GSK's 10-valent pneumococcal conjugate vaccine.
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 study assessing immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine, sponsored by SK Chemicals; the trial status…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Influenza Vaccine and Pneumococcal Vaccine [Phase 4]
Phase 4 clinical trial update on an influenza vaccine and a pneumococcal vaccine, with the study status shown as completed.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults [Phase 1]
This is a Phase 1 study of an investigational pneumococcal vaccine tested at three dose levels in healthy adults; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) [Phase 3]
Phase 3 study of the V110 pneumococcal vaccine in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children [Phase 3]
A Phase 3 study evaluating the safety and immunogenicity of a newly developed 23-valent pneumococcal polysaccharide vaccine in Chinese adult…